Search results
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 1 month agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Sanofi forecasts moderate profit growth on Dupixent demand
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi forecast moderate earnings growth that undershot expectations, saying demand for...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters via Yahoo News· 1 year ago(Reuters) -Sanofi's asthma drug Dupixent met all targets in a trial to treat "smoker's lung",...
Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 2 years agoRegeneron Pharmaceuticals, Inc. REGN is having a good run, with shares gaining 16.4% in the year so...
ASLAN (ASLN) Up 161% on Upbeat Initial Data From Eczema Study
Zacks via Yahoo Finance· 3 months agoASLAN (ASLN) rises on upbeat initial data from a phase II study of eblasakimab in patients with...
Sanofi lifts earnings outlook on new drug launches, Dupixent sales
Reuters via Yahoo Finance· 11 months ago(Reuters) -French drugmaker Sanofi on Friday increased its guidance for full-year earnings, citing...
Regeneron Jumps On Third-Quarter Beat As High-Dose Eylea Delivers
Investor's Business Daily· 7 months agoRegeneron Pharmaceuticals' high-dose Eylea is off to a strong start in the U.S., the company said...
Could Regeneron Stock Help You Retire a Millionaire?
Motley Fool via Yahoo Finance· 5 months agoThere are many ways one could end up with $1 million or more by retirement. Putting enough money in a savings account or winning the lottery are among...
Sanofi (SNY) Q1 2023 Earnings Call Transcript
Motley Fool· 1 year agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY) Q1 2023 Earnings Call Apr 27, 2023, 8:30 a.m. ET Contents: Prepared Remarks Questions and Answers...
Takeda's treatment becomes first oral therapy for esophageal condition in US
Reuters via Yahoo News· 4 months agoThe U.S. health regulator's approval makes the therapy the first oral treatment for the condition,...